Stellant Securities Allots Equity Shares and Warrants Raising Over Rs 43 Crore

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Stellant Securities Allots Equity Shares and Warrants Raising Over Rs 43 Crore

Stellant Securities (India) Ltd has completed a preferential allotment of 678,388 equity shares at Rs 602 per share, raising Rs 40.84 crore. Additionally, the company issued 166,200 warrants to the promoter group, collecting a 25% upfront payment of Rs 2.50 crore. This capital injection follows approvals from shareholders and the BSE, strengthening the company's financial position while impacting the overall equity base.

Stellant Securities Allots Equity Shares and Warrants

Total Capital Raised: Rs 43.34 Crore
Issue Price per Security: Rs 602

Reader Takeaway: Stellant Securities expands its capital base through preferential issuance, with full equity subscription and partial warrant payments received.

What just happened

Stellant Securities (India) Ltd concluded a board meeting on November 4, 2026, officially allotting securities as previously authorized by shareholders. The company successfully issued 678,388 equity shares at a price of Rs 602 each, including a premium of Rs 592, generating total proceeds of Rs 40.84 crore. Furthermore, the company allotted 166,200 warrants to the promoter and promoter group at the same price of Rs 602 per warrant. In line with SEBI (ICDR) regulations, the company has successfully collected 25% of the total consideration for these warrants, totaling Rs 2.50 crore.

Why this matters

The preferential allotment is a key move to strengthen the company’s capital reserves. By issuing shares to non-promoters and warrants to the promoter group, the company is demonstrating both external investor confidence and internal commitment from its leadership. The funds raised will likely support the company's operational growth plans.

The backstory

This transaction follows the approval granted by shareholders during the Extra Ordinary General Meeting held on August 24, 2026. The company also secured the necessary in-principle approval from the BSE Ltd on October 21, 2026, ensuring the process remains compliant with regulatory frameworks.

What to track next

Investors should monitor future regulatory filings for the eventual conversion of the 166,200 warrants into equity shares. This conversion will lead to a further expansion of the company’s outstanding equity base and should be evaluated for potential dilution effects on existing shareholdings.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.